Bulletin
Investor Alert

Company Close Updates Archives | Email alerts

Nov. 17, 2020, 5:01 p.m. EST

Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP slipped 1.64% to $1.20 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.21% to 11,899.34 and Dow Jones Industrial Average DJIA falling 0.56% to 29,783.35. This was the stock's third consecutive day of losses. Corbus Pharmaceuticals Holdings Inc. closed $8.58 below its 52-week high ($9.78), which the company reached on August 31st.

The stock underperformed when compared to some of its competitors Tuesday, as Fate Therapeutics Inc. FATE fell 0.72% to $52.42, Vanda Pharmaceuticals Inc. VNDA rose 0.45% to $13.25, and Viking Therapeutics Inc. VKTX rose 3.22% to $6.42. Trading volume (3.3 M) remained 2.3 million below its 50-day average volume of 5.5 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.